Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Rakesh Sharma

Geriatric Psychiatry Kingston, PA Medical Doctor

NPI 1649205824 CMS profile 120266

562 Wyoming Avenue, Kingston, PA 18704

Open in the dashboard

General payments

$2,898

89 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Rakesh Sharma of Kingston, PA is reported in the CMS Open Payments database as having received $2,898 across 89 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Geriatric Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $36 2
2022 General $59 3
2021 General $17 1
2020 General $402 9
2019 General $2,384 74

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rakesh Sharma
  • Geriatric Psychiatry median
  • Middle half of Geriatric Psychiatry
  • National median

In program year 2025, general payments to Rakesh Sharma were reported at $0. Among 188 Geriatric Psychiatry profiles paid that year, the median was $125 and the middle half received between $52 and $515.

Show as a table
Year Rakesh Sharma Geriatric Psychiatry median Middle half National median
2019 $2,384 $151 $47–$484 $163
2020 $402 $112 $30–$410 $114
2021 $17 $122 $35–$550 $132
2022 $59 $133 $54–$557 $149
2023 $36 $138 $61–$485 $160
2024 $0 $127 $51–$572 $164
2025 $0 $125 $52–$515 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Janssen Pharmaceuticals, Inc $796 23 payments
  2. Neurocrine Biosciences, Inc. $519 14 payments
  3. Teva Pharmaceuticals USA, Inc. $478 11 payments
  4. Alkermes, Inc. $343 13 payments
  5. Sunovion Pharmaceuticals Inc. $270 7 payments
  6. Otsuka America Pharmaceutical, Inc. $122 7 payments
  7. Jazz Pharmaceuticals Inc. $114 1 payment
  8. AbbVie, Inc. $77 4 payments
  9. Allergan Inc. $72 3 payments
  10. Vanda Pharmaceuticals Inc. $64 4 payments
  11. Other $42 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $2,866 88 payments
  2. Education $32 1 payment
Products named General payments · program years 2019–2023
  1. INVEGA SUSTENNA $777 22 payments
  2. INGREZZA $519 14 payments
  3. AUSTEDO $460 10 payments
  4. INVEGA TRINZA $382 13 payments
  5. ARISTADA Cns $343 13 payments
  6. ARISTADA Cns $343 13 payments
  7. ARISTADA Cns $343 13 payments
  8. ARISTADA Cns $343 13 payments
  9. ARISTADA INITIO $343 13 payments
  10. LATUDA $270 7 payments
  11. Other $741 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

34

Median for Psychiatry: 574

Drug cost

$1,126

Median for Psychiatry: $27,624

Branded share of claims

0%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clozapine Generic 13 $878
Olanzapine Generic 21 $249

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 6 billing codes

Paid by Medicare

$4,271

Medicare's payments for the services billed

Medicare patients

23

Average age 59

Services billed

60

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 74%
High blood pressure 70%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Geriatric Psychiatry in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record